Skip to main content
SpringerLink
Log in

Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Type 2 diabetes mellitus is the leading cause of macrovascular diseases and related death. Additionally, diabetes mellitus is frequently complicated by other cardiovascular risk factors, such as hypercholesterolemia, hypertension, obesity, hypercoagulability, and inflammation. We wanted to evaluate and compare the effects of treating with a one-year course of atorvastatin or simvastatin on inflammatory markers such as high sensitive C-reactive protein (hsCRP), fibrinogen, and ferritin in uncontrolled type 2 diabetic patients. Also, we planned to investigate the correlation between inflammatory markers and metabolic parameters. Fifty type 2 diabetic patients (30 women, 20 men; mean age: 49.9 ± 8.5 years) were enrolled into the study. Twenty healthy subjects, matched on body mass index and age, were also included in the study as a control group. Diabetic patients were divided into two groups and received simvastatin or atorvastatin (Group S and A, respectively). After 1 year of statin treatment (Group A), there were significant decreases in total cholesterol (217.3 ± 46.5–173.8 ± 37.2 mg/dl; P < 0.0001), LDL-cholesterol (146.7 ± 50.3–102.3 ± 31.1 mg/dl, P < 0.0001), hsCRP (0.88 ± 0.62–0.35 ± 0.18 mg/dl, P < 0.0001), fibrinogen (258.2 ± 16.9–215.5 ± 10.6 mg/l; P < 0.0001), and ferritin (118.2 ± 73.9–81.2 ± 72.5 ng/ml, P < 0.0001) levels compared to basal values. In the S group, there were significant decreases in total cholesterol (224.4 ± 61.2–175.0 ± 47.8 mg/dl; P < 0.0001), LDL-cholesterol (140.9 ± 56.7–110.9 ± 42.2 mg/dl, P < 0.0001), hsCRP (0.98 ± 1.3–0.46 ± 0.25 mg/dl, P < 0.0001), fibrinogen (265.7 ± 26.8–222.1 ± 20.6 mg/l; P < 0.0001), and ferritin (136.7 ± 101.1–85.6 ± 32.1 ng/ml, P < 0.0001) levels compared to basal values. At the end of the study, ∆hsCRP, ∆fibrinogen, and ∆ferritin levels were correlated with ∆LDL (r = 0.42; P = 0.005, with ∆hsCRP), (r = 0.40; P = 0.008, with ∆fibrinogen), (r = 0.46; P = 0.002, with ∆ferritin) and ∆HDL (r = −0.50; P < 0.0001, with ∆hsCRP), (r = −0.32; p = 0.042, with ∆fibrinogen), (r = −0.48; P < 0.0001, with ∆ferritin) cholesterol levels. Atorvastatin and simvastatin treatments were found to be effective for the control of hypercholesterolemia and resulted in a significant decrease in acute phase reactants in uncontrolled type 2 diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. J. Frohlich, G.Steiner, Int.J.Clin.Pract.Suppl. 113, 14–22 (2000)

    Google Scholar 

  2. C.D. Stehouwer, M.A. Gall, J.W. Twisk, E. Knudsen, J.J. Emeis, H.H. Parving, Diabetes 51, 1157–1165 (2002)

    Article  CAS  PubMed  Google Scholar 

  3. K. Pyorala, T.R. Pedersen, J. Kjekshus, O. Faergeman, A.G. Olsson, G. Thorgeirsson, Diabetes Care 20, 614–620 (1997)

    Article  CAS  PubMed  Google Scholar 

  4. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto, Lancet 361, 2005–2016 (2003)

    Article  PubMed  Google Scholar 

  5. C. Tribouilloy, M. Peltier, L. Colas, M. Senni, O. Ganry, J.L. Rey, J.P. Lesbre, Am.J.Cardiol. 81, 321–326 (1998)

    Article  CAS  PubMed  Google Scholar 

  6. E. Ernst, K.L. Resch, Ann.Intern.Med. 118, 956–963 (1993)

    CAS  PubMed  Google Scholar 

  7. P.M. Ridker, Ann.Intern.Med. 130, 933–937 (1999)

    CAS  PubMed  Google Scholar 

  8. R.P. Tracy, Curr.Opin.Lipidol. 10, 435–441 (1999)

    Article  CAS  PubMed  Google Scholar 

  9. D.A. Morrow, P.M. Ridker, Med.Clin.North Am. 84, 149–161 (2000)

    Article  CAS  PubMed  Google Scholar 

  10. N.S. Rost, P.A. Wolf, C.S. Kase, M. Kelly-Hayes, H. Silbershatz, J.M. Massaro, R.B. D’Agostino, C. Franzblau, P.W. Wilson, Stroke 32, 2575–2579 (2001)

    Article  CAS  PubMed  Google Scholar 

  11. P.M. Ridker, M.J. Stampfer, N. Rifai, JAMA 285, 2481–2485 (2001)

    Article  CAS  PubMed  Google Scholar 

  12. K.A. Mitropoulos, J.M. Armitage, R. Collins, T.W. Meade, B.E. Reeves, K.R. Wallendszus, S.S. Wilson, A. Lawson, R. Peto, Eur. Heart J. 18, 235–241 (1997)

    CAS  PubMed  Google Scholar 

  13. P.M. Ridker, N. Rifai, M. Clearfield, J.R. Downs, S.E. Weis, J.S. Miles, A.M. Gotto Jr., N. Engl. J. Med. 344, 1959–1965 (2001)

    Article  CAS  PubMed  Google Scholar 

  14. E.T. Bairaktari, C.S. Tzallas, V.K. Tsimihodimos, E.N. Liberopoulos, G.A. Miltiadous, M.S. Elisaf, J. Cardiovasc. Risk 6, 113–116 (1999)

    CAS  PubMed  Google Scholar 

  15. A. Bertolotto, S. Bandinelli, L. Ruocco, F.A. Lo, G. Penno, R. Navalesi, Atherosclerosis 143, 455–457 (1999)

    Article  CAS  PubMed  Google Scholar 

  16. C.A. Dujovne, W.S. Harris, R. Altman, R.W. Overhiser, D.M. Black, Am. J. Cardiol. 85, 350–353 (2000)

    Article  CAS  PubMed  Google Scholar 

  17. B.R. Jaeger, B. Meiser, D. Nagel, P. Uberfuhr, J. Thiery, U. Brandl, W. Bruckner, S.W. von, E. Kreuzer, G. Steinbeck, B. Reichart, D. Seidel, Circulation 96, 2–8 (1997)

    Google Scholar 

  18. I.F. McDowell, M. Smye, T. Trinick, J.A. Shortt, M.P. Archibald, E.R. Trimble, D.P. Nicholls, Br. J. Clin. Pharmacol. 31, 340–343 (1991)

    CAS  PubMed  Google Scholar 

  19. J.L. Sullivan, Lancet 1, 1293–1294 (1981)

    Article  CAS  PubMed  Google Scholar 

  20. D.S. Abdalla, A. Campa, H.P. Monteiro, Atherosclerosis 97, 149–159 (1992)

    Article  CAS  PubMed  Google Scholar 

  21. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, J.L. Witztum, N. Engl. J. Med. 320, 915–924 (1989)

    Article  CAS  PubMed  Google Scholar 

  22. E. Porreca, S. Ucchino, F.C. Di, B.N. Di, D. Angelucci, A.M. Napolitano, A. Mezzetti, F. Cuccurullo, Arterioscler. Thromb. 14, 299–304 (1994)

    CAS  PubMed  Google Scholar 

  23. J. Danesh, P. Appleby, Circulation 99, 852–854 (1999)

    CAS  PubMed  Google Scholar 

  24. H. Blackburn, A. Keys, E. Simonson, P. Rautaharju, S. Punsar, Circulation 21, 1160–1175 (1960)

    CAS  PubMed  Google Scholar 

  25. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)

    Article  CAS  PubMed  Google Scholar 

  26. S.A. Doggrell, Rev. Recent Clin. Trials 1, 143–153 (2006)

    Article  CAS  PubMed  Google Scholar 

  27. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais, N. Engl. J. Med. 342, 145–153 (2000)

    Article  CAS  PubMed  Google Scholar 

  28. A. Bowie, D. Owens, P. Collins, A. Johnson, G.H. Tomkin, Atherosclerosis. 102, 63–67 (1993)

    Article  CAS  PubMed  Google Scholar 

  29. M.D. Stringer, P.G. Gorog, A. Freeman, V.V. Kakkar, BMJ. 298, 281–284 (1989)

    Article  CAS  PubMed  Google Scholar 

  30. J.D. Cook, D.A. Lipschitz, L.E. Miles, C.A. Finch, Am. J. Clin. Nutr. 27, 681–687 (1974)

    CAS  PubMed  Google Scholar 

  31. D.W. Reif, R.D. Simmons, Arch. Biochem. Biophys. 283, 537–541 (1990)

    Article  CAS  PubMed  Google Scholar 

  32. C.E. Thomas, L.A. Morehouse, S.D. Aust, J. Biol. Chem. 260, 3275–3280 (1985)

    CAS  PubMed  Google Scholar 

  33. P. Wardman, L.P. Candeias, Radiat. Res. 145, 523–531 (1996)

    Article  CAS  PubMed  Google Scholar 

  34. W.B. Kannel, P.A. Wolf, W.P. Castelli, R.B. D’Agostino, JAMA. 258, 1183–1186 (1987)

    Article  CAS  PubMed  Google Scholar 

  35. T.W. Meade, S. Mellows, M. Brozovic, G.J. Miller, R.R. Chakrabarti, W.R. North, A.P. Haines, Y. Stirling, J.D. Imeson, S.G. Thompson, Lancet 2, 533–537 (1986)

    Article  CAS  PubMed  Google Scholar 

  36. A. Rosengren, L. Wilhelmsen, J. Intern. Med. 239, 499–507 (1996)

    Article  CAS  PubMed  Google Scholar 

  37. H. Tunstall-Pedoe, M. Woodward, R. Tavendale, R. A’Brook, M.K. McCluskey, BMJ. 315, 722–729 (1997)

    CAS  PubMed  Google Scholar 

  38. H. Asakawa, K. Tokunaga, F. Kawakami, J. Diabetes Complicat. 14, 121–126 (2000)

    Article  CAS  PubMed  Google Scholar 

  39. R. Barazzoni, M. Zanetti, G. Davanzo, E. Kiwanuka, P. Carraro, A. Tiengo, P. Tessari, J. Clin. Endocrinol. Metab. 85, 3121–3125 (2000)

    Article  CAS  PubMed  Google Scholar 

  40. M.A. Crook, S. Couchman, P. Tutt, Blood Coagul. Fibrinolysis 7, 586–589 (1996)

    Article  CAS  PubMed  Google Scholar 

  41. C. Erem, A. Hacihasanoglu, S. Celik, E. Ovali, H.O. Ersoz, K. Ukinc, O. Deger, M. Telatar, Med. Princ. Pract. 14, 22–30 (2005)

    Article  PubMed  Google Scholar 

  42. G. Balla, H.S. Jacob, J. Balla, M. Rosenberg, K. Nath, F. Apple, J.W. Eaton, G.M. Vercellotti, J. Biol. Chem. 267, 18148–18153 (1992)

    CAS  PubMed  Google Scholar 

  43. M.B. Juckett, J. Balla, G. Balla, J. Jessurun, H.S. Jacob, G.M. Vercellotti, Am. J. Pathol. 147, 782–789 (1995)

    CAS  PubMed  Google Scholar 

  44. J.T. Rogers, Blood 87, 2525–2537 (1996)

    CAS  PubMed  Google Scholar 

  45. R.M. Missov, R.P. Stolk, J.G. van der Bom, A. Hofman, M.L. Bots, H.A. Pols, D.E. Grobbee, Diabetes Care 19, 157–159 (1996)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Karadeniz Technical University, Trabzon, Turkey

    Kubilay Ukinc, Halil Onder Ersoz, Cihangir Erem & Arif Bayram Hacihasanoglu

  2. Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, 17020, Turkey

    Kubilay Ukinc, Halil Onder Ersoz, Cihangir Erem & Arif Bayram Hacihasanoglu

  3. Department of Haematology, Karadeniz Technical University, Trabzon, Turkey

    Suleyman Sami Karti

Authors
  1. Kubilay Ukinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halil Onder Ersoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cihangir Erem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arif Bayram Hacihasanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suleyman Sami Karti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kubilay Ukinc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ukinc, K., Ersoz, H.O., Erem, C. et al. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. Endocr 35, 380–388 (2009). https://doi.org/10.1007/s12020-009-9157-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-009-9157-3

Keywords

Search

Navigation